Ascend Wellness Holdings (AAWH) Long-Term Deferred Tax (2020 - 2022)
Ascend Wellness Holdings' (AAWH) quarterly Long-Term Deferred Tax came in at $1.8 million in Q3 2022, up 34.0% year-on-year from $1.3 million in Q3 2021, and up 148.79% quarter-over-quarter from $705000.0 in Q2 2022.
Ascend Wellness Holdings (AAWH) Long-Term Deferred Tax (2020 - 2022) Analysis & Trends
Ascend Wellness Holdings' Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $1.8 million for Q3 2022.
- On a quarterly basis, Long-Term Deferred Tax rose 34.0% year-over-year to $1.8 million in Q3 2022; TTM through Sep 2022 was $1.8 million, a 34.0% increase from a year earlier, with the FY2020 full-year figure at $2.4 million, changed N/A from the prior year.
- Long-Term Deferred Tax improved to $1.8 million in Q3 2022 per AAWH's latest filing, from $705000.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $3.5 million in Q2 2021 and bottomed at $705000.0 in Q2 2022.
- The 3-year median for Long-Term Deferred Tax is $2.1 million (2020), against an average of $2.1 million.
- Biggest YoY gain for Long-Term Deferred Tax was 34.0% in 2022; the steepest drop was 79.57% in 2022.
- Year by year, Long-Term Deferred Tax stood at $2.4 million in 2020, then plunged by 45.34% to $1.3 million in 2021, then surged by 34.0% to $1.8 million in 2022.
- Per Business Quant, the three latest AAWH Long-Term Deferred Tax figures stand at $1.8 million (Q3 2022), $705000.0 (Q2 2022), and $1.3 million (Q3 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 705,000.00 |
| Sep 30, 2021 | 1.31 Mn |
| Jun 30, 2021 | 3.45 Mn |
| Mar 31, 2021 | 3.19 Mn |
| Dec 31, 2020 | 2.40 Mn |